To create Avidocins, Pylum engineers the bacteriocin’s phage-like tendrils ... The benefits of the approach are twofold. Firstly, antimicrobial resistance is one of the top global public health ...

Collaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. The funding of up to £500,000 is provided by LifeArc, a medical research ...

leading to antimicrobial resistance (AMR). Glox Therapeutics’ proprietary protein bacteriocin engineering platform allows for the development of potent therapeutics that selectively eradicate ...

This typically requires antibiotic treatment; however, the bacteria may become resistant to antibiotics over time, leading to antimicrobial resistance (AMR). Glox Therapeutics’ proprietary protein ...